ICONvsMerck & Company

ICLR and MRK stock compared: price, dividend, valuation and results, from SEC filings.

ICLR

ICON plc

$195.02

Value $14.9B

+1.89%
ICLR's page

MRK

Merck & Company, Inc.

$143.37

Value $354B

-0.75%
MRK's page

ICON (ICLR) has a market value of $14.9B and Merck & Company (MRK) $354B. Over the last year, with dividends, ICLR moved +20.2% and MRK +58.8%. The P/E is 33.3 for ICLR and 144.5 for MRK. Dividend yield: ICLR none, MRK 2.37%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ICLR$14.9B

    MRK$354B

    MRK is 24 times ICLR

  • Revenue, 12 months

    ICLR$8.2B

    MRK$67.4B

    MRK is 8.2 times ICLR

  • Net income, 12 months

    ICLR$449M

    MRK$2.5B

    MRK is 5.5 times ICLR

  • Operating margin

    ICLR8.7%

    MRK–

  • ROIC

    ICLR4.7%

    MRK3.9%

    0.8 points apart

  • P/E

    ICLR33.3

    MRK144.5

    MRK is 4.3 times ICLR

  • Dividend yield

    ICLR0.0%

    MRK2.4%

    2.4 points apart

  • 5-year return

    ICLR-31.7%

    MRK+98.6%

    130.3 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ICLR-31.7%

MRK+98.6%

5010015020020222023202420252026
Returns by period
PeriodICLRWith dividendsMRKWith dividends
1 year since November 14, 2025+20.2%Price +20.2%+58.8%Price +54.3%
3 years since November 17, 2023-27.8%-10.3% a yearPrice -27.8%+54.4%+15.6% a yearPrice +40.9%
5 years since November 16, 2021-31.7%-7.3% a yearPrice -31.7%+98.6%+14.7% a yearPrice +70.5%
10 years since November 18, 2016+155.9%+9.9% a yearPrice +155.9%+229.5%+12.7% a yearPrice +142.8%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ICLRICONMRKMerck & Company

Valuation

ICLRMRK
Valuation
Price$195.02$143.37
Market value$14.9B$354B
Enterprise value (EV)$17.5B$399B
P/E33.3144.5
P/E, 5-year median37.014.8
P/B1.67.9
EV/EBIT24.483.7
Free cash flow yield5.7%4.2%

Results and growth

ICLRMRK
Results and growth
Revenue, 12 months$8.2B$67.4B
Net income, 12 months$449M$2.5B
Free cash flow, 12 months$857M$14.7B
Earnings per share, 12 months$5.77$0.98
Revenue growth, year on year0.8%1.3%
Revenue growth a year, past+24.2%over 5 years+9.4%over 5 years
EPS growth a year, past-14.0%over 5 years+21.2%over 5 years

Margins and returns on capital

ICLRMRK
Margins and returns on capital
Gross margin23.4%71.8%
Operating margin8.7%–
Net margin5.5%3.6%
ROIC4.7%3.9%
ROE4.9%5.2%

Balance sheet

ICLRMRK
Balance sheet
Cash$809M$9.7B
Total debt$3.5B$53.8B
Net debt / EBITDA2.35.7
Interest cover3.8×2.4×

Dividends and buybacks

ICLRMRK
Dividends and buybacks
Dividend yield–2.4%
Dividend per share, 12 months–$3.40
Dividend growth a year, past–+5.8%over 5 years
Buyback yield5.0%1.4%
Shareholder yield5.0%3.8%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ICLR or MRK

Didn't find what you were looking for?

Ask us
Which is bigger, ICON or Merck & Company?

By market value, Merck & Company ($354B) is about 23.7 times ICON ($14.9B), at today's prices.

How did ICLR and MRK stock do over the last 10 years?

Since November 18, 2016, ICLR's price moved +155.9% and MRK's +142.8%. With dividends: ICLR +155.9% (+9.9% a year), MRK +229.5% (+12.7% a year). Past returns do not predict future ones.

Which pays the higher dividend, ICLR or MRK?

The dividend yield at today's price is none for ICON and 2.37% for Merck & Company. Over the last twelve months they paid – and $3.40 per share.

What is the P/E of ICLR and MRK?

At today's price, the P/E is 33.3 for ICLR and 144.5 for MRK. The median of the last five years was 37.0 and 14.8, which shows where each stands against its own past.

Which has the higher profit margins, ICON or Merck & Company?

Over the last twelve months, the net margin was 5.5% for ICON and 3.6% for Merck & Company, and the operating margin 8.7% and –. Revenue was $8.2B and $67.4B.

Which is the better investment, ICON or Merck & Company?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.